These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 24124593)

  • 1. Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.
    Roca H; Hernandez J; Weidner S; McEachin RC; Fuller D; Sud S; Schumann T; Wilkinson JE; Zaslavsky A; Li H; Maher CA; Daignault-Newton S; Healy PN; Pienta KJ
    PLoS One; 2013; 8(10):e76773. PubMed ID: 24124593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioinformatics approach reveals novel interactions of the OVOL transcription factors in the regulation of epithelial - mesenchymal cell reprogramming and cancer progression.
    Roca H; Pande M; Huo JS; Hernandez J; Cavalcoli JD; Pienta KJ; McEachin RC
    BMC Syst Biol; 2014 Mar; 8():29. PubMed ID: 24612742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 4. OVOL1/2: Drivers of Epithelial Differentiation in Development, Disease, and Reprogramming.
    Saxena K; Srikrishnan S; Celia-Terrassa T; Jolly MK
    Cells Tissues Organs; 2022; 211(2):183-192. PubMed ID: 32932250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVOL2 antagonizes TGF-β signaling to regulate epithelial to mesenchymal transition during mammary tumor metastasis.
    Wu RS; Hong JJ; Wu JF; Yan S; Wu D; Liu N; Liu QF; Wu QW; Xie YY; Liu YJ; Zheng ZZ; Chan EC; Zhang ZM; Li BA
    Oncotarget; 2017 Jun; 8(24):39401-39416. PubMed ID: 28455959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer.
    Mooney SM; Talebian V; Jolly MK; Jia D; Gromala M; Levine H; McConkey BJ
    J Cell Biochem; 2017 Sep; 118(9):2559-2570. PubMed ID: 28266048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OVOL guides the epithelial-hybrid-mesenchymal transition.
    Jia D; Jolly MK; Boareto M; Parsana P; Mooney SM; Pienta KJ; Levine H; Ben-Jacob E
    Oncotarget; 2015 Jun; 6(17):15436-48. PubMed ID: 25944618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells.
    Slabáková E; Kharaishvili G; Smějová M; Pernicová Z; Suchánková T; Remšík J; Lerch S; Straková N; Bouchal J; Král M; Culig Z; Kozubík A; Souček K
    Oncotarget; 2015 Nov; 6(34):36156-71. PubMed ID: 26416355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
    Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
    J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.
    Preca BT; Bajdak K; Mock K; Sundararajan V; Pfannstiel J; Maurer J; Wellner U; Hopt UT; Brummer T; Brabletz S; Brabletz T; Stemmler MP
    Int J Cancer; 2015 Dec; 137(11):2566-77. PubMed ID: 26077342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
    Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
    Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
    Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
    J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
    Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
    J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.
    Xiang X; Deng Z; Zhuang X; Ju S; Mu J; Jiang H; Zhang L; Yan J; Miller D; Zhang HG
    PLoS One; 2012; 7(12):e50781. PubMed ID: 23284647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.